_version_ 1784579801417252864
author Swoboda, Ryszard
Giebel, Sebastian
Knopińska-Posłuszny, Wanda
Chmielowska, Ewa
Drozd-Sokołowska, Joanna
Paszkiewicz-Kozik, Ewa
Kulikowski, Waldemar
Taszner, Michał
Mendrek, Włodzimierz
Najda, Jacek
Czerw, Tomasz
Olszewska-Szopa, Magdalena
Czyż, Anna
Giza, Agnieszka
Spychałowicz, Wojciech
Subocz, Edyta
Szwedyk, Paweł
Krzywon, Aleksandra
Wilk, Agata
Zaucha, Jan Maciej
author_facet Swoboda, Ryszard
Giebel, Sebastian
Knopińska-Posłuszny, Wanda
Chmielowska, Ewa
Drozd-Sokołowska, Joanna
Paszkiewicz-Kozik, Ewa
Kulikowski, Waldemar
Taszner, Michał
Mendrek, Włodzimierz
Najda, Jacek
Czerw, Tomasz
Olszewska-Szopa, Magdalena
Czyż, Anna
Giza, Agnieszka
Spychałowicz, Wojciech
Subocz, Edyta
Szwedyk, Paweł
Krzywon, Aleksandra
Wilk, Agata
Zaucha, Jan Maciej
author_sort Swoboda, Ryszard
collection PubMed
description
format Online
Article
Text
id pubmed-8496665
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-84966652021-10-29 Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma Swoboda, Ryszard Giebel, Sebastian Knopińska-Posłuszny, Wanda Chmielowska, Ewa Drozd-Sokołowska, Joanna Paszkiewicz-Kozik, Ewa Kulikowski, Waldemar Taszner, Michał Mendrek, Włodzimierz Najda, Jacek Czerw, Tomasz Olszewska-Szopa, Magdalena Czyż, Anna Giza, Agnieszka Spychałowicz, Wojciech Subocz, Edyta Szwedyk, Paweł Krzywon, Aleksandra Wilk, Agata Zaucha, Jan Maciej Ann Hematol Correction Springer Berlin Heidelberg 2021-03-24 2021 /pmc/articles/PMC8496665/ /pubmed/33760951 http://dx.doi.org/10.1007/s00277-021-04503-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Swoboda, Ryszard
Giebel, Sebastian
Knopińska-Posłuszny, Wanda
Chmielowska, Ewa
Drozd-Sokołowska, Joanna
Paszkiewicz-Kozik, Ewa
Kulikowski, Waldemar
Taszner, Michał
Mendrek, Włodzimierz
Najda, Jacek
Czerw, Tomasz
Olszewska-Szopa, Magdalena
Czyż, Anna
Giza, Agnieszka
Spychałowicz, Wojciech
Subocz, Edyta
Szwedyk, Paweł
Krzywon, Aleksandra
Wilk, Agata
Zaucha, Jan Maciej
Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma
title Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma
title_full Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma
title_fullStr Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma
title_full_unstemmed Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma
title_short Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma
title_sort correction to: high efficacy of bgd (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory hodgkin lymphoma
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496665/
https://www.ncbi.nlm.nih.gov/pubmed/33760951
http://dx.doi.org/10.1007/s00277-021-04503-1
work_keys_str_mv AT swobodaryszard correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT giebelsebastian correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT knopinskaposłusznywanda correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT chmielowskaewa correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT drozdsokołowskajoanna correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT paszkiewiczkozikewa correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT kulikowskiwaldemar correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT tasznermichał correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT mendrekwłodzimierz correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT najdajacek correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT czerwtomasz correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT olszewskaszopamagdalena correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT czyzanna correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT gizaagnieszka correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT spychałowiczwojciech correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT suboczedyta correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT szwedykpaweł correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT krzywonaleksandra correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT wilkagata correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma
AT zauchajanmaciej correctiontohighefficacyofbgdbendamustinegemcitabineanddexamethasoneinrelapsedrefractoryhodgkinlymphoma